
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality.
Inhaltsverzeichnis
1 Lung Cancer Genomics in the Era of Accelerated Targeted Drug Development. -2 Emerging Biomarkers in Personalized Therapy of Lung Cancer. -3 Epithelial mesenchymal transition in aggressive lung cancers. -4 The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer. -5 The microenvironment of lung cancer and therapeutic implications. -6 Epigenetics in Personalized Management of Lung Cancers. -7 Next-Generation Sequencing and Applications to the Diagnosis and Treatment of Lung Cancer. -8 Nanomedicine for Treatment of Lung Cancer. -9 Personalized Therapy of Small Cell Lung Cancer. -10 Personalized Radiation Therapy for Lung Cancer. -11 Current Clinical Management in the era of personalized therapy. -11 Personalized Therapy of Non-Small Cell Lung Cancer.
Es wurden noch keine Bewertungen abgegeben. Schreiben Sie die erste Bewertung zu "Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management" und helfen Sie damit anderen bei der Kaufentscheidung.